Estriol, conjugated equine estrogens, and alendronate therapy for osteoporosis

Int J Gynaecol Obstet. 2006 Feb;92(2):141-2. doi: 10.1016/j.ijgo.2005.09.026. Epub 2005 Nov 21.
No abstract available

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Alendronate / administration & dosage
  • Alendronate / therapeutic use*
  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / therapeutic use*
  • Estriol / administration & dosage
  • Estriol / therapeutic use*
  • Estrogens / administration & dosage
  • Estrogens / therapeutic use*
  • Estrogens, Conjugated (USP) / administration & dosage
  • Estrogens, Conjugated (USP) / therapeutic use*
  • Female
  • Humans
  • Middle Aged
  • Osteoporosis, Postmenopausal / drug therapy*
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Bone Density Conservation Agents
  • Estrogens
  • Estrogens, Conjugated (USP)
  • Estriol
  • Alendronate